Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000950170-24-007136

Director acquired 834,334 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2024-01-22 Grant or award +834,334 $12.00 $10,012,008 2,762,837 I
Derivatives
Fairmount Funds Management LLC Director 2024-01-22 Grant or award · Pre-Funded Warrants (Right to Buy) +832,333 $12.00 $9,987,164 832,333 I
Loading xslF345X05/ownership.xml…